BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

558 related articles for article (PubMed ID: 21764797)

  • 1. Imaging of the striatal and extrastriatal dopamine transporter with (18)F-LBT-999: quantification, biodistribution, and radiation dosimetry in nonhuman primates.
    Varrone A; Stepanov V; Nakao R; Tóth M; Gulyás B; Emond P; Deloye JB; Vercouillie J; Stabin MG; Jonsson C; Guilloteau D; Halldin C
    J Nucl Med; 2011 Aug; 52(8):1313-21. PubMed ID: 21764797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [11C]LBT-999: a suitable radioligand for investigation of extra-striatal dopamine transporter with PET.
    Saba W; Valette H; Schöllhorn-Peyronneau MA; Coulon C; Ottaviani M; Chalon S; Dolle F; Emond P; Halldin C; Helfenbein J; Madelmont JC; Deloye JB; Guilloteau D; Bottlaender M
    Synapse; 2007 Jan; 61(1):17-23. PubMed ID: 17068778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified quantification and whole-body distribution of [18F]FE-PE2I in nonhuman primates: prediction for human studies.
    Varrone A; Gulyás B; Takano A; Stabin MG; Jonsson C; Halldin C
    Nucl Med Biol; 2012 Feb; 39(2):295-303. PubMed ID: 22033024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of dopamine transporters in human brain using [11C]PE2I and positron emission tomography: evaluation of reference tissue models.
    Seki C; Ito H; Ichimiya T; Arakawa R; Ikoma Y; Shidahara M; Maeda J; Takano A; Takahashi H; Kimura Y; Suzuki K; Kanno I; Suhara T
    Ann Nucl Med; 2010 May; 24(4):249-60. PubMed ID: 20364374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling Part I: PET studies.
    Saba W; Peyronneau MA; Dollé F; Goutal S; Bottlaender M; Valette H
    Nucl Med Biol; 2012 Feb; 39(2):227-33. PubMed ID: 22033025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution and radiation dosimetry of [18F]F-PEB in nonhuman primates.
    Bélanger MJ; Krause SM; Ryan C; Sanabria-Bohorquez S; Li W; Hamill TG; Burns HD
    Nucl Med Commun; 2008 Oct; 29(10):915-9. PubMed ID: 18769310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-body distribution and radiation dosimetry of the dopamine transporter radioligand [(11)C]PE2I in healthy volunteers.
    Ribeiro MJ; Ricard M; Lièvre MA; Bourgeois S; Emond P; Gervais P; Dollé F; Syrota A
    Nucl Med Biol; 2007 May; 34(4):465-70. PubMed ID: 17499737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I.
    Sasaki T; Ito H; Kimura Y; Arakawa R; Takano H; Seki C; Kodaka F; Fujie S; Takahata K; Nogami T; Suzuki M; Fujiwara H; Takahashi H; Nakao R; Fukumura T; Varrone A; Halldin C; Nishikawa T; Suhara T
    J Nucl Med; 2012 Jul; 53(7):1065-73. PubMed ID: 22689927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of serotonin transporter availability with [11C]MADAM--a comparison between the ECAT HRRT and HR systems.
    Schain M; Tóth M; Cselényi Z; Stenkrona P; Halldin C; Farde L; Varrone A
    Neuroimage; 2012 Mar; 60(1):800-7. PubMed ID: 22227138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Analysis of ¹⁸F-(E)-N-(3-Iodoprop-2-Enyl)-2β-Carbofluoroethoxy-3β-(4'-Methyl-Phenyl) Nortropane Binding to the Dopamine Transporter in Parkinson Disease.
    Fazio P; Svenningsson P; Forsberg A; Jönsson EG; Amini N; Nakao R; Nag S; Halldin C; Farde L; Varrone A
    J Nucl Med; 2015 May; 56(5):714-20. PubMed ID: 25791993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo PET quantification of the dopamine transporter in rat brain with [¹⁸F]LBT-999.
    Sérrière S; Tauber C; Vercouillie J; Guilloteau D; Deloye JB; Garreau L; Galineau L; Chalon S
    Nucl Med Biol; 2014 Jan; 41(1):106-13. PubMed ID: 24210285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates.
    Hillmer AT; Zheng MQ; Li S; Scheunemann M; Lin SF; Holden D; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Carson RE; Brust P; Huang Y
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):537-47. PubMed ID: 26455500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain and whole-body imaging in nonhuman primates with [11C]MeS-IMPY, a candidate radioligand for beta-amyloid plaques.
    Seneca N; Cai L; Liow JS; Zoghbi SS; Gladding RL; Hong J; Pike VW; Innis RB
    Nucl Med Biol; 2007 Aug; 34(6):681-9. PubMed ID: 17707808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Difficulties in dopamine transporter radioligand PET analysis: the example of LBT-999 using [18F] and [11C] labelling: part II: Metabolism studies.
    Peyronneau MA; Saba W; Dollé F; Goutal S; Coulon C; Bottlaender M; Valette H
    Nucl Med Biol; 2012 Apr; 39(3):347-59. PubMed ID: 22154687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosynthesis and in vivo evaluation of [(11)C]MP-10 as a positron emission tomography radioligand for phosphodiesterase 10A.
    Plisson C; Salinas C; Weinzimmer D; Labaree D; Lin SF; Ding YS; Jakobsen S; Smith PW; Eiji K; Carson RE; Gunn RN; Rabiner EA
    Nucl Med Biol; 2011 Aug; 38(6):875-84. PubMed ID: 21843784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body distribution and brain tumor imaging with (11)C-4DST: a pilot study.
    Toyohara J; Nariai T; Sakata M; Oda K; Ishii K; Kawabe T; Irie T; Saga T; Kubota K; Ishiwata K
    J Nucl Med; 2011 Aug; 52(8):1322-8. PubMed ID: 21764794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.
    Beauregard JM; Croteau E; Ahmed N; van Lier JE; Bénard F
    J Nucl Med; 2009 Jan; 50(1):100-7. PubMed ID: 19091905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution, radiation dose estimates, and in vivo Pgp modulation studies of 18F-paclitaxel in nonhuman primates.
    Kurdziel KA; Kiesewetter DO; Carson RE; Eckelman WC; Herscovitch P
    J Nucl Med; 2003 Aug; 44(8):1330-9. PubMed ID: 12902425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodistribution and human dosimetry of enantiomer-1 of the synthetic leucine analog anti-1-amino-2-fluorocyclopentyl-1-carboxylic acid.
    Nye JA; Jarkas N; Schuster DM; Savir-Baruch B; Voll RJ; Camp VM; Goodman MM
    Nucl Med Biol; 2011 Oct; 38(7):1035-41. PubMed ID: 21741251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution and radiation dosimetry of the integrin marker 18F-RGD-K5 determined from whole-body PET/CT in monkeys and humans.
    Doss M; Kolb HC; Zhang JJ; Bélanger MJ; Stubbs JB; Stabin MG; Hostetler ED; Alpaugh RK; von Mehren M; Walsh JC; Haka M; Mocharla VP; Yu JQ
    J Nucl Med; 2012 May; 53(5):787-95. PubMed ID: 22499613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.